The glia-derived, neurotrophic protein S100 has been implicated in development and maintenance of the nervous system. However, S100 has also been postulated to play a role in mechanisms of neuropathology, because of its specific localization and selective overexpression in Alzheimer's disease. To begin to address the question of whether S100 can induce potentially toxic signaling pathways, we examined the effects of the protein on nitric oxide synthase (NOS) activity in cultures of rat cortical astrocytes. S100 treatment of astrocytes induced a time-and dose-dependent increase in accumulation of the NO metabolite, nitrite, in the conditioned medium. The S100-stimulated nitrite production was blocked by cycloheximide and by the NOS inhibitor N-nitro-L-arginine methylester, but not by the inactive D-isomer of the inhibitor. Direct measurement of NOS enzymatic activity in cell extracts and analysis of NOS mRNA levels showed that the NOS activated by S100 addition is the calcium-independent, inducible isoform. Furthermore, the specificity of the effects of S100 on activation of NOS was demonstrated by the inability of S100␣ and calmodulin to induce an increase in nitrite levels. Our data indicate that S100 can induce a potent activation of inducible NOS in astrocytes, an observation that might have relevance to the role of S100 in neuropathology.The normal development and maintenance of the brain involves the temporal and spatial coordination and proper functioning of a number of intracellular and cell-cell signaling events, and the contribution of glial cells to these signaling processes is becoming more widely appreciated. The classical concept of the role of glia in brain function is rapidly changing with newer evidence of the crucial nature of these cells in controlling neurotransmitter levels, maintaining calcium homeostasis, and synthesizing and releasing neurotrophic and growth factors (for review, see Ref. 1). One such glia-derived factor is S100, a protein that promotes neuritic outgrowth of specific neuronal populations (e.g. cortical (2, 3), dorsal root ganglia (4), serotonergic (5, 6), and motoneurons (7)) and enhances survival of neurons during development (7,8) and after insult (9). S100 is also a glial mitogen, inducing phosphoinositide hydrolysis, increases in intracellular calcium, and protooncogene expression (10, 11). These trophic functions require nanomolar concentrations of a disulfide-linked S100 dimer (see Ref. 12). Thus, S100 may be beneficial during development of the nervous system, and increased S100 expression and secretion following acute glial activation in response to central nervous system injury may be one mechanism the brain uses in attempts to repair injured neurons.However, S100 may also reach concentrations that are deleterious, e.g. in neurodegenerative diseases like Alzheimer's disease and Down syndrome where chronic glial activation occurs (13). It has been found that S100 levels in severely affected brain regions of Alzheimer's disease patients are severalfol...